I have come to realize more so everyday – disregard mainstream analysts, Wall Street recommendations, and even MorningStar ratings, due to the inherent conflict of interest between the firms and their particular clientèle. Here is the point: YOU, are NOT Wall Street’s client. YOU are the CONSUMER of the products sold FOR Wall Street’s clients. […]
Microblogs
December 1, 2017
Guru-ish Pundits
I have come to realize more so everyday – disregard mainstream analysts, Wall Street recommendations, and even MorningStar ratings, due to the inherent conflict of interest between the firms and their particular clientèle. Here is the point: YOU, are NOT Wall Street’s client. YOU are the CONSUMER of the products sold FOR Wall Street’s clients. […]
Recent Author Comments
Posted on June 26, 2019
Posted on October 22, 2018
As per the issues alluded to by Travis TrackX Holdings Inc. (TKXHF) may not make too much sense fundamentally now, but from a technical point of view quite attractive: * Has just broken through resistance and 200MA in concerted upward momentum of 75 +; * A[...]
Posted on October 3, 2018
Motley Fool has been advocating The Trade Desk, Inc. (TTD) for some time.I tend to agree with Travis on the attractive medium / long term prospects of TTD. Market cap of $6 Bill with average trading volume of 1 Mill.Technically sound, since enterin[...]
Posted on September 5, 2018
Agree with Hugh R, technically leaning more towards cold than luke warm. Trading above 200MA but below 50MA & 100MA, with narrow association between signal and divergence in a lateral movement on MACD with reduced trading volumes indicative of a continued[...]
Posted on August 31, 2018
These days there are umpteen articles, publications and discussion groups on Pot Stocks, with new ones seeing the light daily in anticipation of the legalization of recreational use of Cannabis in Canada on 17 October 2018. The general consensus, especiall[...]
Posted on August 23, 2018
The Pot is certainly Cooking - it is without a doubt the hottest and most talked about sector.Motley Fool recently published the Five Marijuana Stocks With the Highest Expected Sales Next Year: 1. Canopy Growth Corp. (CGC) : $687.8 million 2. Aphria [...]
Posted on August 18, 2018
Genprex, Inc. (GNPX) - Rodney Varner, Chairman and CEO, remarked during the recent Clinical and Corporate Update for Second Quarter 2018: “We have made significant progress in recent months to advance the development of Oncoprex™ for treatment of non-s[...]
Posted on August 14, 2018
Thx deanbob, will certainly go that route when my current subscription expires.[...]
Posted on August 13, 2018
Hi TravisSo I have the choice to subscribe to Forest’s letter for $2000; or yours for $59 / annum (which I have just renewed after the first year) only to find out that from yours now (@ $59) advising against investing in ECSIF or later from Forrests[...]
Posted on August 9, 2018
Comprehensive recount Travis, thx ...Aerojet Rocketdyne Holdings, Inc. (AJRD) is one of the more attractive opportunities touted by the pundits lately soliciting subscriptions. Operating in an industry that attracts continued attention on account of wo[...]
Posted on July 28, 2018
AMZN is and remains one of the most amazing companies in the world. It churns out impressive earnings out time and again. A stock that trades uninterrupted above 200MA for 3½ years with continued upward momentum is a feat on its own.Making a statemen[...]
Posted on July 18, 2018
I am subscribed to Oxford Club - Why? - No one knows. Their site is so convoluted, incomprehensible and totally impenetrable that it is impossible to find the said punt. The only accessibility is for solicitation to subscribe to more of their guruish punts[...]
Posted on July 18, 2018
It will be a discovery of majestic proportions to discover a drug which is effective for dyslipidaemias - incorrect / elevated ratios of the sub-fractions of cholesterol since the total cholesterol value per-se should be of limited significance whether tre[...]
Posted on July 16, 2018
Hon Hai Precision Industry Co., Ltd. (HNHPF) traded in Aug 2008 at ± $6.00. It closed today (i.e. 10 years later) at $5.43. From 52 week high in Aug 2017 it has retraced by 35% to current levels.Despite market cap of $48 Bill still trading on OTC mar[...]
Posted on July 15, 2018
Deanbob, regrettably all businesses and enterprises will be affected. South Africa is literally a boiling pot tethering on the brink of boiling over. With the EFF (Economic Freedom Fighters), one of the extremist opposition parties pushing very hard for a [...]
Posted on July 13, 2018
Naspers (the name derived from Nasional Pers, meaning National Media) hails from my native country, South Africa. With a 20% pullback since mid January 2018 may seem like a good entry point but in my humble opinion is not investable now. Trading in the “[...]
Posted on June 23, 2018
Hillary Kramer has been punting GWPH for some time as well., which was featured on StockGumshoe in March 2017: https://www.stockgumshoe.com/reviews/gamechangers-2/kramer-if-you-dont-take-a-small-position-in-this-marijuana-stock-youll-regret-it-for-the-res[...]
Posted on June 23, 2018
Hi Dana Send me an e-mail to info@stockmidas.com - will forward you an evaluation report on WNDW.[...]
Posted on June 22, 2018
In the late 2016’s SCON retraced from $3.50 levels down to trading around the $1.00 mark where it has been trading sideways for 18 months ever since, having closed at exactly $1.00 yesterday.A concern is that since it trades on the Nasdaq in the eve[...]
Posted on June 20, 2018
Dear Griffin As an early retired MD / anesthetist (now thankfully full time trader .. lol) I can assure you that the symptoms from heart and lung disease can certainly be confused. If you consider the physiology of the human body – in very simple terms t[...]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info Please note that this is your publicly visible biography - we recommend not including any personal information (phone, email, address, etc.) and ONLY linking to any other pages or profiles you're comfortable sharing with everyone.
The "news" of Opiant's revolutionary Narcan Spray designed for reversing the effects of an opiate overdose broke in the first part of 2017. The stock price ramped up from $ 6 to $50 within a space of two months,only to tank down again and has been trading[...]